{"nct_id":"NCT04381650","title":"A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors","status":"COMPLETED","status_verified_date":"2025-04","start_date":"2020-08-17","start_date_type":"ACTUAL","primary_completion_date":"2024-10-29","primary_completion_date_type":"ACTUAL","completion_date":"2024-10-29","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["TAK"]}